Regional Capacity Development in Vaccines Production for Vaccine Sovereignty in IsDB MCs

Webinar (11:30 - 13:30 PM KSA Time)


The Islamic Development Bank is pleased to invite you to the Annual Meetings Side Event webinar entitled “Regional Capacity Development in Vaccines Production for Vaccine Sovereignty in IsDB MCs” on 25th Wednesday, May 2022, from 11:30 AM to 13:30 PM Jeddah

IsDB Group has approved since its inception more than US$ 7 Billion for various programs in the Health Sector, including US$ 427 million to bridge the critical financial gaps for Polio Eradication and US$ 50.00 million for Malaria Quick-win Program, which benefited eight African Member Countries (MC)s, and last year US$ 2.3 billion for IsDB Covid-19 ‘Strategic Preparedness and Response Program’ (IsDB SPRP). The Bank’s support is coordinated with the Global Partners effort, including global financial institutions (World Bank and African Development Bank), UN Agencies (WHO, UNICEF, UNDP, WFP) and IFRC.

The objectives of the Side Event are to:

  • Showcase success stories of Institut Pasteur of Dakar, VACSERA Egypt, Biofarma Indonesia; and
  • Provide strategic recommendations.

The panellists and participants will discuss (i) challenges and opportunities related to the development, production, procurement and deployment of vaccines to address the future pandemics and its  health crisis; (ii) what it will take to finance vaccines’ production sustainably; and (iii) country experiences in raising the domestic resources required to respond to vaccine development and production.


  1. Mr Abdunur M. Sekindi, Professional Officer, Science & Technology, OIC General Secretariat.
  2. Dr Amadou Alpha SALL, DG Pasteur Institute, Senegal.
  3. Dr Matthew Downham, PhD, Director, Manufacturing & Supply Chain Networks, CEPI.
  4. Mr Philip G. Semprevio II, JD, CLP, Director, Technology Transactions, Mount Sinai Innovation Partners, Mount Sinai Health System.
  5. Dr Samir Machour, Vice President of Samsung Biologics, Samsung.